Huiping Liu
@LiuCluster
Mission to eliminate cancer and target circulating tumor stem cell clusters at the Pharm Dept @NUFeinbergMed @LurieCancer center, as a member of @the_asci.
We are honored to see our @CD_AACR paper on #Glycosylation of #breast #circulating #tumor cell clusters discussed in the Spotlight Commentary by Nicola Aceto @CR_AACR. Thanks to the Liu Cluster hero @DNurmaa who did the work @LurieCancer @NUFeinbergMed. doi.org/10.1158/2159-8…
Congrats to Dr. David Scholten, PhD who successfully defended his thesis on CTC-DPT clusters, accepted by @jclinicalinvest. What a rewarding moment - celebrate with his family/friends, Cluster mates, and our Chair @nupharm1 @NUFeinbergMed @LurieCancer biorxiv.org/content/10.110…
#AACRai25 cochairs Valentina Boeva and Benjamin Haibe-Kains adjourned the AACR Conference on Artificial Intelligence and Machine Learning. We thank all of the chairs—including @MarzyehGhassemi and @BoWang87—for developing an outstanding program. @val_boeva @bhaibeka
Just had the pleasure of being interviewed by @Nature on the rise of AI in digital pathology. With growing workloads and global shortages of pathologists, the field is turning to AI not as a luxury—but as a necessity. Full article: nature.com/articles/d4158… In the article, I…
Empowering Biomedical Discovery with "AI Scientists”: Marinka Zitnik addressed this topic in a keynote lecture at the AACR Special Conference on Artificial Intelligence and Machine Learning. #AACRai25 @marinkazitnik
Congratulations Rokana! Look forward to welcoming you back home for joint adventure again @NorthwesternU @NorthwesternMed @LurieCancer
I’ve just graduated residency from @UT_Pathology. I’m deeply grateful for the mentorship, especially from our Chair, Dr. Gohara, a true legend. I’m honored to have received the "Distinguished Resident Award" and inspired by her words as I embark on my Fellowship at @NU_Pathology.
2025 Nature Index: Harvard has dropped to No. 2 after the Chinese Academy of Sciences. No. 1 and 3-9 are all Chinese research institutes. Meanwhile, American research institutes are facing a 43% cut in NIH funding and a 50% cut in NSF funding. Please, don’t look up.
Congratulations to Feng Yue, PhD, Director of @LurieCancer’s Center for Cancer #Genomics, on being inducted into the 2025 class of the American Institute for Medical and Biological Engineering! news.feinberg.northwestern.edu/2025/06/09/yue… @yuefeng_1 @aimbe
The @LurieCancer (LCC) went thru competing renewal of NCI designation. For a 2nd time we got "exceptional" ranking. The NCI site visit team gave a "perfect exceptional" (equivalent to 10). LCC is one of few in the nation and the only one in IL to ever achieve exceptional status.
Hope for best & prepare for worst. Two miracles came one day - congrats to (1) very talented @FangjiaTong on receiving @ACS_Research postdoc fellowship @AmericanCancer (2) authors on Plexin-B2 preprint accepted for publication @LurieCancer @NorthwesternU doi.org/10.1101/2023.0…
It’s time again for Cell Biology at Scale (CB@S), an annual gathering for researchers from diverse disciplines to share ideas on how new technologies can transform #cellbiology! Co-hosted by #CZBiohubNY & @ChanZuckerberg. Learn more and register: czbiohub.org/events/cell-bi…
“We have now entered an era of different treatments that I call therapy intensification,” says @LurieCancer’s Maha Hussain, MD, about multi-modality strategies to curb aggressive #prostatecancer. Read the full story in @TIME: time.com/7286596/joe-bi…
So much learned at the FASEB SRC meeting on Cellular Plasticity in Cancer in HK this past week! Thank you to all the speakers and participants for sharing your expertise. Special shout out to co-organizers @JustinLathia and @VivianLiLab. @FASEBorg #CPCSRC…
Great AM session at #CPCSRC @FASEBorg featuring mechanisms of plasticity in metastasis - great presentations by @LiuCluster and @KarunaMDPhD
Great start to the @FASEBorg cancer stem plasticity meeting in Hong Kong with @stephaniema912 kicking things off and a Keynote talk from Hans Clevers from @Roche
Our research doesn’t just stay in the lab. 🥼 Life-saving clinical trials revolutionize patient care, transforming medicine and training the physicians who will deliver it.
If you’re attending the major symposium on #Mitochondrial Biology in Cancer at #AACR25, listen to this #BreakthroughsPodcast episode with chair and presenter Navdeep Chandel, PhD, of @LurieCancer about the impact of his pioneering research: feinberg.northwestern.edu/research/podca… #metabolism
Today, the FDA is taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods. fda.gov/news-events/pr…